Abeona Therapeutics (ABEO) Payables (2010 - 2026)

Abeona Therapeutics' Payables history runs 17 years deep, the most recent figure standing at $4.1 million for Q1 2026.

• On a quarterly basis, Payables fell 18.87% year-over-year to $4.1 million in Q1 2026; TTM through Mar 2026 was $4.1 million, a 18.87% decrease from a year earlier, with the FY2025 full-year figure at $7.9 million, up 129.26% from the prior year.
• Payables declined to $4.1 million in Q1 2026 per ABEO's latest filing, from $7.9 million in the prior quarter.
• Across five years, Payables topped out at $7.9 million in Q4 2025 and bottomed at $1.6 million in Q1 2022.
• The 5-year median for Payables is $3.1 million (2024), against an average of $3.6 million.
• Across the five-year window, Payables slumped 58.13% in 2022 and surged 136.75% in 2025, its largest moves.
• Year by year, Payables stood at $1.8 million in 2022, then climbed by 2.6% to $1.9 million in 2023, then soared by 85.2% to $3.4 million in 2024, then surged by 129.26% to $7.9 million in 2025, then tumbled by 48.4% to $4.1 million in 2026.
• Per Business Quant, the three latest ABEO Payables figures stand at $4.1 million (Q1 2026), $7.9 million (Q4 2025), and $5.9 million (Q3 2025).